FDA Commissioner's Exit: A Symbol of Compromised Public Health The resignation of Marty Makary as Food and Drug Administration (FDA) Commissioner has sparked widespread concern over the Trump administration's handling of public health policy.
Makary stepped down after being forced to approve the sale of fruit flavored e cigarettes, a decision that raises questions about the power dynamics at play within the administration.
President Trump praised Makary as a "hard worker" and "outstanding career in Medicine," but the underlying reasons for his departure suggest a deeper conflict between the Commissioner's commitment to public health and the White House's priorities.